Cobra BioManufacturing Further Strengthens Management Team

Cobra Biomanufacturing Plc (London Stock Exchange AIM) announced that it has strengthened its senior management team. Martin Comberbach PhD, Director of GMP Manufacturing Operations, comes from a pharmaceutical process and project engineering background having held senior positions at GSK’s Rixensart vaccine facility, Metris Therapeutics Ltd, and more recently as Director of Global Manufacturing for GeneMedix Plc.

Back to news